Expansion Therapeutics

Expansion Therapeutics

Biotechnology, 9880 Campus Point Dr Ste 310, Jupiter, Florida, 92121, United States, 11-50 Employees

expansionrx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is EXPANSION THERAPEUTICS

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellect...

Read More

map
  • 9880 Campus Point Dr Ste 310, Jupiter, Florida, 92121, United States Headquarters: 9880 Campus Point Dr Ste 310, Jupiter, Florida, 92121, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7996

checked-icon Does something look wrong? Fix it. | View contact records from EXPANSION THERAPEUTICS

Expansion Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Expansion Therapeutics

Answer: Expansion Therapeutics's headquarters are located at 9880 Campus Point Dr Ste 310, Jupiter, Florida, 92121, United States

Answer: Expansion Therapeutics's phone number is 85********

Answer: Expansion Therapeutics's official website is https://expansionrx.com

Answer: Expansion Therapeutics's revenue is $1 Million to $5 Million

Answer: Expansion Therapeutics's SIC: 7996

Answer: Expansion Therapeutics has 11-50 employees

Answer: Expansion Therapeutics is in Biotechnology

Answer: Expansion Therapeutics contact info: Phone number: 85******** Website: https://expansionrx.com

Answer: Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The companys initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options. Expansion is based in Jupiter, Florida

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access